The Importance of Newborn Genetic Screening for Early Identification of GJB2 and SLC26A4 Related Hearing Loss
Otolaryngology–Head and Neck Surgery · 2025
DOI: 10.1002/ohn.1188 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2025. Verfasst von Emily R Wener und 6 weiteren Autor:innen. Beteiligte Einrichtung: Archie's Cochlear Implant Laboratory, Neuroscience & Mental Health, Hospital for Sick Children, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Connexin 26, Sulfate Transporters, Neonatal Screening, Genetic Testing. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To assess the added benefit of newborn genetic screening for GJB2 and SLC26A4 variants in conjunction with newborn hearing screening. Study Design Retrospective cohort study.
Methods
Children with known variants of GJB2 and SLC26A4 were identified from 485 children with hearing loss who underwent testing with Next Generation Sequencing (NGS) between January 2015 and February 2018, prior to expanded screening for genetic variants and congenital CMV. Children with two pathogenic or likely pathogenic variants of GJB2 or SLC26A4 were considered to have genetic hearing loss. NGS genetic data were compared to variants included in the expanded genetic screen for all newborns in Ontario and newborn hearing screening results.
Setting
Canadian tertiary pediatric hospital.
Results
Thirty‐five children with GJB2 and SLC26A4‐ associated hearing loss were identified by NGS (n = 27 GJB2 ‐HL; n = 8 SLC26A4 ‐HL). Of these, 20 (57%) had been identified by newborn hearing screening (14/27 52% GJB2 ‐HL; 6/8 75% SLC26A4 ‐HL). Ten of the 20 (50%) would also have been identified by genetic screening if it had been available (9/14 64% GJB2 ‐HL; 1/6 17% SLC26A4 ‐HL). An additional 8 children with GJB2 or SLC26A4‐ associated hearing loss passed their newborn hearing screen but showed hearing loss later; three of these children (38%) would have been identified by newborn genetic screening (3/6 GJB2 ‐HL; 0/2 SLC26A4 ‐HL).
Conclusion
Genetic and hearing screening modalities in Ontario's expanded newborn hearing screening program improve early identification of children with hearing loss including those at risk of being missed by hearing screening alone. This was most clear for children with GJB2 ‐hearing loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Archie's Cochlear Implant Laboratory, Neuroscience & Mental Health, Hospital for Sick Children, Toronto, Ontario, Canada.
- Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Hospital for Sick Children, Toronto, Ontario, Canada.
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
- Genome Diagnostics Paediatric Laboratory Medicine, Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Division of Clinical & Metabolic Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Department of Genetic Counselling, The Hospital for Sick Children, Toronto, Ontario, Canada.
ORCID-Profile: Emily R Wener
Zitieren
APA
Wener, E. R., Cushing, S. L., Papsin, B. C., Stavropoulos, D. J., Mendoza-Londono, R., Quercia, N., & Gordon, K. A. (2025). The Importance of Newborn Genetic Screening for Early Identification of GJB2 and SLC26A4 Related Hearing Loss. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1188
Vancouver
Wener ER, Cushing SL, Papsin BC, Stavropoulos DJ, Mendoza-Londono R, Quercia N, et al. The Importance of Newborn Genetic Screening for Early Identification of GJB2 and SLC26A4 Related Hearing Loss. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1188
BibTeX
@article{Wener2025,
author = {Wener, Emily R and Cushing, Sharon L and Papsin, Blake C and Stavropoulos, Dimitrios J and Mendoza-Londono, Roberto and Quercia, Nada and Gordon, Karen A},
title = {The Importance of Newborn Genetic Screening for Early Identification of GJB2 and SLC26A4 Related Hearing Loss},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2025},
doi = {10.1002/ohn.1188}
}
EUVIMED